Skip to content

Author

Jie Xu

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Discovery of 2, 4-disubstituted pyrimidine derivatives as selective HIPK2 inhibitors for potential treatment of chronic kidney disease.

AF-1 and AF-2 represent antifibrotic candidates with a new chemical scaffold, submicromolar HIPK2 inhibitory activity, and improved subtype selectivity within the HIPK family for the treatment of CKD-associated renal fibrosis.

Xinlan Hu, Hanyi Ouyang, Chunyu Feng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.